Latest News Archive

Please select Category, Year, and then Month to display items

International Award for UFS Department of Nuclear Medicine

07 July 2023 | Story André Damons | Photo Supplied

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS launches expansions to Biotechnology Building

2015-11-04

Biotechnology Building
Photo: Leonie Bolleurs

To support the strategic focus of the University of the Free State (UFS) on teaching and learning in the field of Biotechnology, the Department of Microbial, Biochemical, and Food Biotechnology introduced upgrades and additions to the value of R23 million to the existing Biotechnology Building on its Bloemfontein Campus. The funding was provided by the Department of Higher Education and Training.

The new section, together with renovations to the existing part of the Biotechnology Building, was opened on Thursday 29 October 2015.

The Department, consisting of three disciplines - Microbiology, Biochemistry, and Food Biotechnology - is extremely diverse. Two of the three disciplines – Microbiology and Biochemistry – are housed in the Biotechnology Building.

Additions and renovations to the Biotechnology Building include:
- Four new research laboratories
- Nine revamped research laboratories

At the launch of the Biotechnology Building were,
from the left: Nico Janse van Rensburg,
Senior Director: University Estates;
Maureen Khati, University Estates,
Prof Nicky Morgan, Vice Rector: Operations
and Ria Deysel, Director: Facilities Management.
Photo: Leonie Bolleurs

The work to the building will have dramatic effects on the quality, as well as the quantity, of postgraduate students. Given the national priority to deliver students, this is very important, particularly at the doctorate level.

Prof Koos Albertyn from the Department said these were the first renovations and expansions done to the building since 1 January 1990. “We welcome the extra space. Forty-six more postgraduate students can now be accommodated in the department,” he said.

Construction took place on the south-western corner of the existing building. Further developments to the building include:
-   Six new offices
-   A lecture hall for 70 students
-   Laboratories that can accommodate 56 postgraduate students

Prof Martie Smit, Academic Head of the Department, said: “This new and refurbished facility enables us to give our best. As academics, we are committed to doing our part in delivering high-quality education at both undergraduate and postgraduate levels to students envisaging a future in biotechnology.”

The James Charles du Preez Seminar Room was also opened at the event. The seminar room is dedicated to Prof Du Preez – who was Head of the Department from October 2002 until the end of 2014. He played a major role in raising funds for upgrading the Biotechnology Building, including the addition of a new wing.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept